PMC:7461420 / 86639-86838
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T410 | 63-67 | Disease | denotes | SARS | http://purl.obolibrary.org/obo/MONDO_0005091 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T42860 | 6-16 | Chemical | denotes | nucleoside | http://purl.obolibrary.org/obo/CHEBI_33838 |
| T44765 | 178-188 | Chemical | denotes | remdesivir | http://purl.obolibrary.org/obo/CHEBI_145994 |
LitCovid-PubTator
| Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
|---|---|---|---|---|---|
| 2685 | 63-73 | Species | denotes | SARS‐CoV‐2 | Tax:2697049 |
| 2686 | 92-96 | Species | denotes | CoVs | Tax:11118 |
| 2688 | 6-16 | Chemical | denotes | nucleoside | MESH:D009705 |
| 2689 | 178-188 | Chemical | denotes | remdesivir | MESH:C000606551 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T752 | 0-199 | Sentence | denotes | These nucleoside analogs have shown remarkable potency against SARS‐CoV‐2 and other related CoVs in vitro and in vivo, with IC50 values in the low nanomolar range, outperforming remdesivir 3–10‐fold. |